Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated
